Newsquawk Logo

Novo Nordisk (NVO) US Chief says twice as many medicare patients prefer GLP-1 pill to shot; seeking bolt-on M&A to boost portfolio

ByNewsquawk Staff
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#NOVO NORDISK A/S#NVO.US#EU SESSION#US SESSION#EUROPEAN EQUITIES
Published: Updated:
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.